Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis
Open Access
- 9 December 2019
- Vol. 16 (2), e1905233
- https://doi.org/10.1002/smll.201905233
Abstract
Hepatocellular carcinoma (HCC) is the third leading cause of cancer‐related death worldwide. The prognosis of HCC remains very poor; thus, an effective treatment remains urgent. Herein, a type of nanomedicine is developed by conjugating Fe@Fe3O4 nanoparticles with ginsenoside Rg3 (NpRg3), which achieves an excellent coupling effect. In the dimethylnitrosamine‐induced HCC model, NpRg3 application significantly prolongs the survival of HCC mice. Further research indicates that NpRg3 application significantly inhibits HCC development and eliminates HCC metastasis to the lung. Notably, NpRg3 application delays HCC‐induced ileocecal morphology and gut microbial alterations more than 12 weeks during HCC progression. NpRg3 administration elevates the abundance of Bacteroidetes and Verrucomicrobia, but decreases Firmicutes. Twenty‐nine predicted microbial gene functions are enriched, while seven gene functions are reduced after NpRg3 administration. Moreover, the metabolomics profile presents a significant progression during HCC development, but NpRg3 administration corrects tumor‐dominant metabolomics. NpRg3 administration decreases 3‐indolepropionic acid and urea, but elevates free fatty acids. Importantly, NpRg3 application remodels the unbalanced correlation networks between gut microbiota and metabolism during HCC therapy. In conclusion, nanoparticle conjugation of ginsenoside Rg3 inhibits HCC development and metastasis via the remodeling of unbalanced gut microbiota and metabolism in vivo, providing an antitumor therapy strategy.Keywords
Funding Information
- National Natural Science Foundation of China (81600506, 81702757, 81702346, 81702927, 51371018)
- National Basic Research Program of China (2018YFC2000501)
- China Postdoctoral Science Foundation (2017M610463, 2018M632814)
This publication has 40 references indexed in Scilit:
- Liver Ischemic Preconditioning (IPC) Improves Intestinal Microbiota Following Liver Transplantation in Rats through 16s rDNA-Based Analysis of Microbial Structure ShiftPLOS ONE, 2013
- Predictive functional profiling of microbial communities using 16S rRNA marker gene sequencesNature Biotechnology, 2013
- Metabolic Reconstruction for Metagenomic Data and Its Application to the Human MicrobiomePLoS Computational Biology, 2012
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4Cancer Cell, 2012
- FLASH: fast length adjustment of short reads to improve genome assembliesBioinformatics, 2011
- UCHIME improves sensitivity and speed of chimera detectionBioinformatics, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Enteric dysbiosis associated with a mouse model of alcoholic liver diseaseJournal of Hepatology, 2010
- Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial TaxonomyApplied and Environmental Microbiology, 2007
- Chemometrics in MetabonomicsJournal of Proteome Research, 2006